Cervical Cancer · By FIGO Stage + Approach
IA1 conization/hysterectomy; IA2 modified radical + nodes; IB1-2/IIA1 radical hysterectomy (open superior to minimally invasive LACC); early small-volume fertility-sparing trachelectomy; locally advanced concurrent chemoradiation.
Locally advanced → concurrent chemoradiation: Locally advanced IB3 / II-IVA → definitive concurrent chemoradiation (platinum-based) + brachytherapy; surgery is not first-line.
Step-by-step decision
Choose step by step as prompted; reaching an endpoint gives the management recommendation. You can go back a step or restart anytime.
🎓 Want to practice? Do a case challenge with this pathway → (get a case, choose management step by step, scored).
Full pathway
- [Decision] FIGO stage + fertility wishFIGO stage? LVSI? Fertility-sparing?
- IA1, no LVSI → IA1 no LVSI → conization/hysterectomy
- IA1+LVSI / IA2 → IA1+LVSI/IA2 → modified radical + nodes
- IB1-IB2 / IIA1 (early, operable) → IB1-2/IIA1 → radical hysterectomy
- Early, small tumor (generally ≤2 cm), young wanting fertility preservation → Early small-volume → radical trachelectomy
- Locally advanced IB3 / II-IVA → Locally advanced → concurrent chemoradiation
- [End] IA1 no LVSI → conization/hysterectomyIA1 no LVSI → cervical conization (negative margins, wants fertility) or extrafascial total hysterectomy (completed childbearing); follow-up.
- [End] IA1+LVSI/IA2 → modified radical + nodesIA1+LVSI / IA2 → modified radical hysterectomy + pelvic nodes/sentinel; radical trachelectomy for those wanting fertility.
- [End] IB1-2/IIA1 → radical hysterectomyIB1-IB2 / IIA1 → radical hysterectomy + pelvic lymph node dissection (± sentinel); open abdominal is superior to minimally invasive (LACC trial: minimally invasive had worse disease-free/overall survival); high-risk factors (margin/parametrial/node positive) → adjuvant chemoradiation.
- [End] Early small-volume → radical trachelectomyEarly, small tumor (generally ≤2 cm), young wanting fertility preservation → radical trachelectomy + pelvic node assessment.
- [End] Locally advanced → concurrent chemoradiationLocally advanced IB3 / II-IVA → definitive concurrent chemoradiation (platinum-based) + brachytherapy; surgery is not first-line.
Source guidelines & references
- Cervical cancer management (NCCN/ESGO; LACC trial open superior to minimally invasive radical surgery)
This pathway is our own synthesis of the decision logic in the guidelines above (not the guideline verbatim); thresholds and workflows change as guidelines update — in practice follow the latest guideline, your institution's protocol and the individual patient.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.